article

New Article Published: Nerofe Phase I trial summaryDecember 11, 2017

The Phase I Nerofe (dTCApFs) human trial summary has been published in the Molecular and Clinical Oncology Journal.

In this trial Nerofe was found to be safe and well‑tolerated, and potentially efficacious as an anti-cancer agent.

11 Dec|

Nerofe Pre-clinical Paper Published in Molecular and Clinical Oncology JournalOctober 21, 2017

Link To Article

21 Oct|